Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia

Hypertension

Volumn 59, Issue 5, 2012, Pages 1014-1020

  Morton, Jude S ^a,b   Abdalvand, Ali ^a,b   Jiang, Yanyan ^a,b   Sawamura, Tatsuya ^c   Uwiera, Richard R E ^a   Davidge, Sandra T ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Cardiovascular Research Centre   (Canada)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

LOX 1 receptor; Oxidized LDL; Preeclampsia; RUPP; Vascular function

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEROXYNITRITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; NONHUMAN; PERFUSION PRESSURE; PLACENTA INSUFFICIENCY; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASODILATATION;

ANIMALS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE III; PERFUSION; PEROXYNITROUS ACID; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PRESSURE; RANDOM ALLOCATION; RATS; REFERENCE VALUES; SCAVENGER RECEPTORS, CLASS E; STATISTICS, NONPARAMETRIC; SUPEROXIDES;

EID: 84862819937     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.191825     Document Type: Article

References (40)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365: 785-799. (Pubitemid 40311367)
2. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension. 2003;41:437-445. (Pubitemid 36314613)
3. James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol. 2010;221:363-378.
4. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7:375-384.
5. Lima VJ, Andrade CR, Ruschi GE, Sass N. Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Med J. 2011;129:73-76.
6. Ogura K, Miyatake T, Fukui O, Nakamura T, Kameda T, Yoshino G. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb. 2002;9:42-47.
7. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small lowdensity lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 1998; 47:1281-1288. (Pubitemid 28469258)
8. Belo L, Caslake M, Gaffney D, Santos-Silva A, Pereira-Leite L, Quintanilha A, Rebelo I. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis. 2002;162:425-432. (Pubitemid 34457949)
9. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89:403-408. (Pubitemid 27086096)
10. Llurba E, Casals E, Domínguez C, Delgado J, Mercadé I, Crispi F, Martín-Gallán P, Cabero L, Gratacós E. Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia. Metabolism. 2005;54:1504-1509. (Pubitemid 41527021)
11. Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Fukaya T. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstet Gynecol. 2000;96:55-59. (Pubitemid 30336280)
12. Belo L, Santos-Silva A, Caslake M, Pereira-Leite L, Quintanilha A, Rebelo I. Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size. Atherosclerosis. 2005;183:185-186. (Pubitemid 41416839)
13. Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension. 2009;53:270-277.
14. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, Lo Cascio V, Sawamura T. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem. 2001;276: 13750-13755.
15. Navarra T, Del Turco S, Berti S, Basta G. The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. J Atheroscler Thromb. 2010;17:317-331.
16. Ogura S, Kakino A, Sato Y, Fujita Y, Iwamoto S, Otsui K, Yoshimoto R, Sawamura T. Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J. 2009;73:1993-1999.
17. Granger JP, LaMarca BBD, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia placenta and trophoblast. Methods Mol Med. 2006;122: 383-392.
18. McCarthy FP, Kingdom JC, Kenny LC, Walsh SK. Animal models of preeclampsia; uses and limitations. Placenta. 2011;32:413-419.
19. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension. 2000;35:367-372. (Pubitemid 30054201)
20. Ramirez RJJ, Debrah J, Novak J. Increased myogenic responses of resistance-sized mesenteric arteries after reduced uterine perfusion pressure in pregnant rats. Hypertens Preg. 2011;30:45-57.
21. Tam Tam KB, George E, Cockrell K, Arany M, Speed J, Martin JN Jr, Lamarca B, Granger JP. Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol. 2011;204:330.e1-330.e4.
22. Sholook MM, Gilbert JS, Sedeek MH, Huang M, Hester RL, Granger JP. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol. 2007;293:H2080-H2084. (Pubitemid 47605844)
23. Reho JJ, Peck J, Novak J, Ramirez RJ. Hypertension induced by episodic reductions in uteroplacental blood flow in gravid rat. Hypertens Preg. 2011;30:208-220.
24. Walsh SK, English FA, Johns EJ, Kenny LC. Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. Hypertension. 2009;54: 345-351.
25. Giardina JB, Cockrell KL, Granger JP, Khalil RA. Low-salt diet enhances vascular reactivity and Ca2αentry in pregnant rats with normal and reduced uterine perfusion pressure. Hypertension. 2002;39:368-374. (Pubitemid 34165151)
26. Murphy JG, Herrington JN, Granger JP, Khalil RA. Enhanced [Ca2α]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure. Am J Physiol Heart Circ Physiol. 2003;284: H393-H403. (Pubitemid 36076308)
27. LaMarca BBD, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-. Hypertension. 2005;46:1022-1025.
28. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble Fms-like tyrosine kinase-1 expression. Hypertension. 2007;50: 1142-1147. (Pubitemid 350172938)
29. Anderson CM, Lopez F, Zhang H-Y, Pavlish K, Benoit JN. Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant sprague-dawley rat. Biol Reprod. 2005;72:762-766. (Pubitemid 40279856)
30. Llinas MT, Alexander BT, Capparelli MF, Carroll MA, Granger JP. Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Hypertension. 2004;43:623-628. (Pubitemid 38282438)
31. Chen X, Zhang H, McAfee S, Zhang C. The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dys-function in ApoE knockout mice. Am J Physiol Heart Circ Physiol. 2010;299:H605-H612.
32. Hag AMF, Kristoffersen US, Pedersen SF, Gutte H, Lebech A-M, Kjaer A. Regional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats. PLoS One. 2009;4:e8170.
33. Wang L-j, Yu Y-h, Zhang L-g, Wang Y, Niu N, Li Q, Guo L-m. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: Correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur J Pharmacol. 2008;597:75-80.
34. Nagase M, Hirose S, Sawamura T, Masaki T, Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun. 1997;237: 496-498. (Pubitemid 27434712)
35. Andersson IJ, Sankaralingam S, Davidge ST. Restraint stress up-regulates lectin-like oxidized low-density lipoprotein receptor-1 in aorta of apolipoprotein E-deficient mice. Stress. 2010;13:454-460.
36. Peshavariya HM, Dusting GJ, Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res. 2007;41:699-712. (Pubitemid 46845591)
37. LeBlanc AJ, Reyes R, Kang LS, Dailey RA, Stallone JN, Moningka NC, Muller-Delp JM. Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1713-R1723.
38. McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC. Peroxisome proliferator-activated receptor-as a potential therapeutic target in the treatment of preeclampsia. Hypertension. 2011;58:280-286.
39. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999;33:83-89. (Pubitemid 29061846)
40. Anderson CM, Lopez F, Zhang H-Y, Shirasawa Y, Pavlish K, Benoit JN. Mesenteric vascular responsiveness in a rat model of pregnancy-induced hypertension. Exp Biol Med. 2006;231:1398-1402. (Pubitemid 44330575)